Segall Bryant & Hamill LLC lessened its stake in Surgery Partners, Inc. (NASDAQ:SGRY – Free Report) by 3.9% during the 3rd quarter, HoldingsChannel reports. The firm owned 303,467 shares of the company’s stock after selling 12,395 shares during the quarter. Segall Bryant & Hamill LLC’s holdings in Surgery Partners were worth $9,784,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Quarry LP raised its position in Surgery Partners by 133.1% during the second quarter. Quarry LP now owns 3,082 shares of the company’s stock worth $73,000 after acquiring an additional 1,760 shares during the period. KBC Group NV raised its position in shares of Surgery Partners by 31.8% during the 3rd quarter. KBC Group NV now owns 2,385 shares of the company’s stock worth $77,000 after purchasing an additional 576 shares during the last quarter. DekaBank Deutsche Girozentrale lifted its stake in Surgery Partners by 102.0% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after buying an additional 1,375 shares in the last quarter. Creative Planning purchased a new position in Surgery Partners in the 3rd quarter valued at about $258,000. Finally, Versor Investments LP acquired a new stake in Surgery Partners in the 3rd quarter worth about $271,000.
Surgery Partners Trading Up 3.8 %
NASDAQ SGRY opened at $23.36 on Friday. Surgery Partners, Inc. has a 12 month low of $21.36 and a 12 month high of $36.92. The stock has a market capitalization of $2.97 billion, a P/E ratio of -48.67, a PEG ratio of 16.71 and a beta of 2.76. The firm’s 50-day moving average is $30.15 and its two-hundred day moving average is $28.40. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66.
Analyst Upgrades and Downgrades
Several analysts recently commented on the company. Cantor Fitzgerald reiterated an “overweight” rating and set a $43.00 price target on shares of Surgery Partners in a research report on Friday, October 4th. UBS Group assumed coverage on shares of Surgery Partners in a research report on Monday, October 14th. They issued a “buy” rating and a $38.00 target price for the company. Royal Bank of Canada lowered their price target on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a research report on Wednesday. KeyCorp started coverage on shares of Surgery Partners in a report on Friday, October 11th. They issued a “sector weight” rating for the company. Finally, Macquarie restated an “outperform” rating and set a $34.00 target price on shares of Surgery Partners in a report on Tuesday. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company. According to MarketBeat, Surgery Partners currently has an average rating of “Moderate Buy” and a consensus price target of $38.71.
Get Our Latest Analysis on Surgery Partners
About Surgery Partners
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Featured Stories
- Five stocks we like better than Surgery Partners
- 3 Fintech Stocks With Good 2021 Prospects
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- How to invest in marijuana stocks in 7 stepsĀ
- TJX Companies Stock Poised to Hit a New High This Year
Want to see what other hedge funds are holding SGRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surgery Partners, Inc. (NASDAQ:SGRY – Free Report).
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.